id	sid	tid	token	lemma	pos
aiua-6490	1	1	archivio	archivio	PROPN
aiua-6490	1	2	italiano	italiano	X
aiua-6490	1	3	di	di	X
aiua-6490	1	4	urologia	urologia	PROPN
aiua-6490	1	5	e	e	PROPN
aiua-6490	1	6	andrologia	andrologia	NOUN
aiua-6490	1	7	2017	2017	NUM
aiua-6490	1	8	;	;	PUNCT
aiua-6490	1	9	89	89	NUM
aiua-6490	1	10	,	,	PUNCT
aiua-6490	1	11	2160	2160	NUM
aiua-6490	1	12	case	case	NOUN
aiua-6490	1	13	report	report	VERB
aiua-6490	1	14	acute	acute	ADJ
aiua-6490	1	15	urinary	urinary	ADJ
aiua-6490	1	16	retention	retention	NOUN
aiua-6490	1	17	after	after	ADP
aiua-6490	1	18	venlafaxine	venlafaxine	ADJ
aiua-6490	1	19	use	use	NOUN
aiua-6490	1	20	şaban	şaban	NOUN
aiua-6490	1	21	oğuz	oğuz	NUM
aiua-6490	1	22	demirdöğen	demirdöğen	NOUN
aiua-6490	1	23	1	1	NUM
aiua-6490	1	24	,	,	PUNCT
aiua-6490	1	25	esen	esen	ADJ
aiua-6490	1	26	yıldırım	yıldırım	NOUN
aiua-6490	1	27	demirdöğen	demirdöğen	NOUN
aiua-6490	1	28	2	2	NUM
aiua-6490	1	29	,	,	PUNCT
aiua-6490	1	30	şenol	şenol	ADJ
aiua-6490	1	31	adanur	adanur	NOUN
aiua-6490	1	32	1	1	NUM
aiua-6490	1	33	1	1	NUM
aiua-6490	1	34	urology	urology	NOUN
aiua-6490	1	35	department	department	PROPN
aiua-6490	1	36	atatürk	atatürk	PROPN
aiua-6490	1	37	university	university	PROPN
aiua-6490	1	38	,	,	PUNCT
aiua-6490	1	39	turkey	turkey	PROPN
aiua-6490	1	40	;	;	PUNCT
aiua-6490	1	41	2	2	NUM
aiua-6490	1	42	department	department	NOUN
aiua-6490	1	43	of	of	ADP
aiua-6490	1	44	child	child	NOUN
aiua-6490	1	45	and	and	CCONJ
aiua-6490	1	46	adolescent	adolescent	ADJ
aiua-6490	1	47	psychiatry	psychiatry	PROPN
aiua-6490	1	48	atatürk	atatürk	PROPN
aiua-6490	1	49	university	university	PROPN
aiua-6490	1	50	,	,	PUNCT
aiua-6490	1	51	turkey	turkey	PROPN
aiua-6490	1	52	.	.	PUNCT
aiua-6490	2	1	we	we	PRON
aiua-6490	2	2	describe	describe	VERB
aiua-6490	2	3	a	a	DET
aiua-6490	2	4	case	case	NOUN
aiua-6490	2	5	of	of	ADP
aiua-6490	2	6	lower	low	ADJ
aiua-6490	2	7	urinary	urinary	ADJ
aiua-6490	2	8	system	system	NOUN
aiua-6490	2	9	symptoms	symptom	NOUN
aiua-6490	2	10	(	(	PUNCT
aiua-6490	2	11	lusss	lusss	NOUN
aiua-6490	2	12	)	)	PUNCT
aiua-6490	2	13	and	and	CCONJ
aiua-6490	2	14	acute	acute	ADJ
aiua-6490	2	15	urinary	urinary	ADJ
aiua-6490	2	16	retention	retention	NOUN
aiua-6490	2	17	that	that	PRON
aiua-6490	2	18	developed	develop	VERB
aiua-6490	2	19	after	after	ADP
aiua-6490	2	20	treatment	treatment	NOUN
aiua-6490	2	21	with	with	ADP
aiua-6490	2	22	a	a	DET
aiua-6490	2	23	low	low	ADJ
aiua-6490	2	24	dose	dose	NOUN
aiua-6490	2	25	of	of	ADP
aiua-6490	2	26	venlafaxine	venlafaxine	NOUN
aiua-6490	2	27	.	.	PUNCT
aiua-6490	3	1	a	a	DET
aiua-6490	3	2	48	48	NUM
aiua-6490	3	3	-	-	PUNCT
aiua-6490	3	4	year	year	NOUN
aiua-6490	3	5	-	-	PUNCT
aiua-6490	3	6	old	old	ADJ
aiua-6490	3	7	male	male	ADJ
aiua-6490	3	8	patient	patient	NOUN
aiua-6490	3	9	was	be	AUX
aiua-6490	3	10	admitted	admit	VERB
aiua-6490	3	11	to	to	ADP
aiua-6490	3	12	our	our	PRON
aiua-6490	3	13	clinic	clinic	NOUN
aiua-6490	3	14	because	because	SCONJ
aiua-6490	3	15	of	of	ADP
aiua-6490	3	16	difficulty	difficulty	NOUN
aiua-6490	3	17	urinating	urinate	VERB
aiua-6490	3	18	,	,	PUNCT
aiua-6490	3	19	an	an	DET
aiua-6490	3	20	intermittent	intermittent	ADJ
aiua-6490	3	21	stream	stream	NOUN
aiua-6490	3	22	,	,	PUNCT
aiua-6490	3	23	and	and	CCONJ
aiua-6490	3	24	trickling	trickle	VERB
aiua-6490	3	25	at	at	ADP
aiua-6490	3	26	the	the	DET
aiua-6490	3	27	end	end	NOUN
aiua-6490	3	28	of	of	ADP
aiua-6490	3	29	urination	urination	NOUN
aiua-6490	3	30	,	,	PUNCT
aiua-6490	3	31	together	together	ADV
aiua-6490	3	32	with	with	ADP
aiua-6490	3	33	urinary	urinary	ADJ
aiua-6490	3	34	retention	retention	NOUN
aiua-6490	3	35	that	that	PRON
aiua-6490	3	36	had	have	AUX
aiua-6490	3	37	started	start	VERB
aiua-6490	3	38	about	about	ADP
aiua-6490	3	39	45	45	NUM
aiua-6490	3	40	days	day	NOUN
aiua-6490	3	41	ago	ago	ADV
aiua-6490	3	42	.	.	PUNCT
aiua-6490	4	1	the	the	DET
aiua-6490	4	2	patient	patient	NOUN
aiua-6490	4	3	had	have	AUX
aiua-6490	4	4	been	be	AUX
aiua-6490	4	5	taking	take	VERB
aiua-6490	4	6	venlafaxine	venlafaxine	NOUN
aiua-6490	4	7	for	for	ADP
aiua-6490	4	8	the	the	DET
aiua-6490	4	9	previous	previous	ADJ
aiua-6490	4	10	6	6	NUM
aiua-6490	4	11	months	month	NOUN
aiua-6490	4	12	.	.	PUNCT
aiua-6490	5	1	the	the	DET
aiua-6490	5	2	drug	drug	NOUN
aiua-6490	5	3	had	have	AUX
aiua-6490	5	4	been	be	AUX
aiua-6490	5	5	prescribed	prescribe	VERB
aiua-6490	5	6	by	by	ADP
aiua-6490	5	7	the	the	DET
aiua-6490	5	8	psychiatry	psychiatry	PROPN
aiua-6490	5	9	department	department	PROPN
aiua-6490	5	10	for	for	ADP
aiua-6490	5	11	a	a	DET
aiua-6490	5	12	diagnosis	diagnosis	NOUN
aiua-6490	5	13	of	of	ADP
aiua-6490	5	14	major	major	ADJ
aiua-6490	5	15	depression	depression	NOUN
aiua-6490	5	16	,	,	PUNCT
aiua-6490	5	17	and	and	CCONJ
aiua-6490	5	18	the	the	DET
aiua-6490	5	19	dose	dose	NOUN
aiua-6490	5	20	had	have	AUX
aiua-6490	5	21	been	be	AUX
aiua-6490	5	22	increased	increase	VERB
aiua-6490	5	23	from	from	ADP
aiua-6490	5	24	75	75	NUM
aiua-6490	5	25	mg	mg	NUM
aiua-6490	5	26	/	/	SYM
aiua-6490	5	27	day	day	NOUN
aiua-6490	5	28	to	to	ADP
aiua-6490	5	29	150	150	NUM
aiua-6490	5	30	mg	mg	NUM
aiua-6490	5	31	/	/	SYM
aiua-6490	5	32	day	day	NOUN
aiua-6490	5	33	1.5	1.5	NUM
aiua-6490	5	34	months	month	NOUN
aiua-6490	5	35	earlier	early	ADV
aiua-6490	5	36	.	.	PUNCT
aiua-6490	6	1	the	the	DET
aiua-6490	6	2	patients	patient	NOUN
aiua-6490	6	3	’	'	PUNCT
aiua-6490	6	4	symptoms	symptom	NOUN
aiua-6490	6	5	were	be	AUX
aiua-6490	6	6	thought	think	VERB
aiua-6490	6	7	to	to	PART
aiua-6490	6	8	be	be	AUX
aiua-6490	6	9	related	relate	VERB
aiua-6490	6	10	to	to	ADP
aiua-6490	6	11	venlafaxine	venlafaxine	NOUN
aiua-6490	6	12	,	,	PUNCT
aiua-6490	6	13	and	and	CCONJ
aiua-6490	6	14	the	the	DET
aiua-6490	6	15	symptoms	symptom	NOUN
aiua-6490	6	16	disappeared	disappear	VERB
aiua-6490	6	17	completely	completely	ADV
aiua-6490	6	18	after	after	SCONJ
aiua-6490	6	19	venlafaxine	venlafaxine	NOUN
aiua-6490	6	20	was	be	AUX
aiua-6490	6	21	replaced	replace	VERB
aiua-6490	6	22	with	with	ADP
aiua-6490	6	23	agomelatine	agomelatine	NOUN
aiua-6490	6	24	.	.	PUNCT
aiua-6490	7	1	we	we	PRON
aiua-6490	7	2	concluded	conclude	VERB
aiua-6490	7	3	that	that	SCONJ
aiua-6490	7	4	the	the	DET
aiua-6490	7	5	lusss	lusss	NOUN
aiua-6490	7	6	and	and	CCONJ
aiua-6490	7	7	urinary	urinary	ADJ
aiua-6490	7	8	retention	retention	NOUN
aiua-6490	7	9	were	be	AUX
aiua-6490	7	10	due	due	ADJ
aiua-6490	7	11	to	to	ADP
aiua-6490	7	12	the	the	DET
aiua-6490	7	13	venlafaxine	venlafaxine	ADJ
aiua-6490	7	14	treatment	treatment	NOUN
aiua-6490	7	15	.	.	PUNCT
aiua-6490	8	1	key	key	ADJ
aiua-6490	8	2	words	word	NOUN
aiua-6490	8	3	:	:	PUNCT
aiua-6490	8	4	acute	acute	ADJ
aiua-6490	8	5	urinary	urinary	ADJ
aiua-6490	8	6	retention	retention	NOUN
aiua-6490	8	7	;	;	PUNCT
aiua-6490	8	8	lower	low	ADJ
aiua-6490	8	9	urinary	urinary	ADJ
aiua-6490	8	10	tract	tract	NOUN
aiua-6490	8	11	symptoms	symptom	NOUN
aiua-6490	8	12	;	;	PUNCT
aiua-6490	8	13	venlafaxine	venlafaxine	NOUN
aiua-6490	8	14	.	.	PUNCT
aiua-6490	8	15	submitted	submit	VERB
aiua-6490	8	16	17	17	NUM
aiua-6490	8	17	december	december	PROPN
aiua-6490	8	18	2016	2016	NUM
aiua-6490	8	19	;	;	PUNCT
aiua-6490	8	20	accepted	accept	VERB
aiua-6490	8	21	11	11	NUM
aiua-6490	8	22	january	january	PROPN
aiua-6490	8	23	2017	2017	NUM
aiua-6490	8	24	summary	summary	NOUN
aiua-6490	8	25	no	no	DET
aiua-6490	8	26	conflict	conflict	NOUN
aiua-6490	8	27	of	of	ADP
aiua-6490	8	28	interest	interest	NOUN
aiua-6490	8	29	declared	declare	VERB
aiua-6490	8	30	.	.	PUNCT
aiua-6490	9	1	and	and	CCONJ
aiua-6490	9	2	had	have	AUX
aiua-6490	9	3	started	start	VERB
aiua-6490	9	4	after	after	SCONJ
aiua-6490	9	5	the	the	DET
aiua-6490	9	6	venlafaxine	venlafaxine	ADJ
aiua-6490	9	7	dosage	dosage	NOUN
aiua-6490	9	8	had	have	AUX
aiua-6490	9	9	been	be	AUX
aiua-6490	9	10	increased	increase	VERB
aiua-6490	9	11	from	from	ADP
aiua-6490	9	12	37.5	37.5	NUM
aiua-6490	9	13	mg	mg	NOUN
aiua-6490	9	14	twice	twice	ADV
aiua-6490	9	15	daily	daily	ADV
aiua-6490	9	16	(	(	PUNCT
aiua-6490	9	17	75	75	NUM
aiua-6490	9	18	mg	mg	NOUN
aiua-6490	9	19	/	/	SYM
aiua-6490	9	20	day	day	NOUN
aiua-6490	9	21	)	)	PUNCT
aiua-6490	9	22	to	to	ADP
aiua-6490	9	23	75	75	NUM
aiua-6490	9	24	mg	mg	NOUN
aiua-6490	9	25	twice	twice	ADV
aiua-6490	9	26	daily	daily	ADV
aiua-6490	9	27	(	(	PUNCT
aiua-6490	9	28	150	150	NUM
aiua-6490	9	29	mg	mg	NUM
aiua-6490	9	30	/	/	SYM
aiua-6490	9	31	day	day	NOUN
aiua-6490	9	32	)	)	PUNCT
aiua-6490	9	33	1.5	1.5	NUM
aiua-6490	9	34	months	month	NOUN
aiua-6490	9	35	earlier	early	ADV
aiua-6490	9	36	.	.	PUNCT
aiua-6490	10	1	the	the	DET
aiua-6490	10	2	patient	patient	NOUN
aiua-6490	10	3	had	have	VERB
aiua-6490	10	4	no	no	DET
aiua-6490	10	5	history	history	NOUN
aiua-6490	10	6	of	of	ADP
aiua-6490	10	7	significant	significant	ADJ
aiua-6490	10	8	disease	disease	NOUN
aiua-6490	10	9	or	or	CCONJ
aiua-6490	10	10	abdominal	abdominal	ADJ
aiua-6490	10	11	or	or	CCONJ
aiua-6490	10	12	urologic	urologic	ADJ
aiua-6490	10	13	surgery	surgery	NOUN
aiua-6490	10	14	,	,	PUNCT
aiua-6490	10	15	and	and	CCONJ
aiua-6490	10	16	his	his	PRON
aiua-6490	10	17	family	family	NOUN
aiua-6490	10	18	history	history	NOUN
aiua-6490	10	19	revealed	reveal	VERB
aiua-6490	10	20	nothing	nothing	PRON
aiua-6490	10	21	of	of	ADP
aiua-6490	10	22	significance	significance	NOUN
aiua-6490	10	23	.	.	PUNCT
aiua-6490	11	1	a	a	DET
aiua-6490	11	2	physical	physical	ADJ
aiua-6490	11	3	examination	examination	NOUN
aiua-6490	11	4	revealed	reveal	VERB
aiua-6490	11	5	a	a	DET
aiua-6490	11	6	vesical	vesical	ADJ
aiua-6490	11	7	globe	globe	NOUN
aiua-6490	11	8	.	.	PUNCT
aiua-6490	12	1	kidney	kidney	NOUN
aiua-6490	12	2	-	-	PUNCT
aiua-6490	12	3	ureter	ureter	NOUN
aiua-6490	12	4	-	-	PUNCT
aiua-6490	12	5	bladder	bladder	NOUN
aiua-6490	12	6	film	film	NOUN
aiua-6490	12	7	was	be	AUX
aiua-6490	12	8	normal	normal	ADJ
aiua-6490	12	9	.	.	PUNCT
aiua-6490	13	1	no	no	DET
aiua-6490	13	2	pathology	pathology	NOUN
aiua-6490	13	3	was	be	AUX
aiua-6490	13	4	observed	observe	VERB
aiua-6490	13	5	in	in	ADP
aiua-6490	13	6	the	the	DET
aiua-6490	13	7	abdomen	abdoman	NOUN
aiua-6490	13	8	or	or	CCONJ
aiua-6490	13	9	urinary	urinary	ADJ
aiua-6490	13	10	system	system	NOUN
aiua-6490	13	11	on	on	ADP
aiua-6490	13	12	ultrasonography	ultrasonography	NOUN
aiua-6490	13	13	,	,	PUNCT
aiua-6490	13	14	and	and	CCONJ
aiua-6490	13	15	no	no	DET
aiua-6490	13	16	pathology	pathology	NOUN
aiua-6490	13	17	was	be	AUX
aiua-6490	13	18	found	find	VERB
aiua-6490	13	19	on	on	ADP
aiua-6490	13	20	cranial	cranial	ADJ
aiua-6490	13	21	and	and	CCONJ
aiua-6490	13	22	lumbar	lumbar	NOUN
aiua-6490	13	23	magnetic	magnetic	ADJ
aiua-6490	13	24	resonance	resonance	NOUN
aiua-6490	13	25	images	image	NOUN
aiua-6490	13	26	.	.	PUNCT
aiua-6490	14	1	a	a	DET
aiua-6490	14	2	transurethral	transurethral	ADJ
aiua-6490	14	3	(	(	PUNCT
aiua-6490	14	4	tu	tu	PROPN
aiua-6490	14	5	)	)	PUNCT
aiua-6490	14	6	catheter	catheter	NOUN
aiua-6490	14	7	was	be	AUX
aiua-6490	14	8	placed	place	VERB
aiua-6490	14	9	,	,	PUNCT
aiua-6490	14	10	as	as	SCONJ
aiua-6490	14	11	the	the	DET
aiua-6490	14	12	patient	patient	NOUN
aiua-6490	14	13	had	have	VERB
aiua-6490	14	14	a	a	DET
aiua-6490	14	15	vesical	vesical	ADJ
aiua-6490	14	16	globe	globe	NOUN
aiua-6490	14	17	.	.	PUNCT
aiua-6490	15	1	a	a	DET
aiua-6490	15	2	urine	urine	NOUN
aiua-6490	15	3	culture	culture	NOUN
aiua-6490	15	4	was	be	AUX
aiua-6490	15	5	sterile	sterile	ADJ
aiua-6490	15	6	.	.	PUNCT
aiua-6490	16	1	the	the	DET
aiua-6490	16	2	results	result	NOUN
aiua-6490	16	3	of	of	ADP
aiua-6490	16	4	urodynamic	urodynamic	ADJ
aiua-6490	16	5	tests	test	NOUN
aiua-6490	16	6	were	be	AUX
aiua-6490	16	7	normal	normal	ADJ
aiua-6490	16	8	.	.	PUNCT
aiua-6490	17	1	no	no	DET
aiua-6490	17	2	urogenital	urogenital	ADJ
aiua-6490	17	3	system	system	NOUN
aiua-6490	17	4	pathology	pathology	NOUN
aiua-6490	17	5	was	be	AUX
aiua-6490	17	6	found	find	VERB
aiua-6490	17	7	that	that	PRON
aiua-6490	17	8	could	could	AUX
aiua-6490	17	9	explain	explain	VERB
aiua-6490	17	10	the	the	DET
aiua-6490	17	11	patient	patient	NOUN
aiua-6490	17	12	’s	’s	PART
aiua-6490	17	13	condition	condition	NOUN
aiua-6490	17	14	,	,	PUNCT
aiua-6490	17	15	and	and	CCONJ
aiua-6490	17	16	a	a	DET
aiua-6490	17	17	psychiatry	psychiatry	NOUN
aiua-6490	17	18	consultation	consultation	NOUN
aiua-6490	17	19	was	be	AUX
aiua-6490	17	20	therefore	therefore	ADV
aiua-6490	17	21	requested	request	VERB
aiua-6490	17	22	to	to	PART
aiua-6490	17	23	evaluate	evaluate	VERB
aiua-6490	17	24	whether	whether	SCONJ
aiua-6490	17	25	the	the	DET
aiua-6490	17	26	problem	problem	NOUN
aiua-6490	17	27	was	be	AUX
aiua-6490	17	28	associated	associate	VERB
aiua-6490	17	29	with	with	ADP
aiua-6490	17	30	the	the	DET
aiua-6490	17	31	venlafaxine	venlafaxine	ADJ
aiua-6490	17	32	treatment	treatment	NOUN
aiua-6490	17	33	.	.	PUNCT
aiua-6490	18	1	the	the	DET
aiua-6490	18	2	psychiatry	psychiatry	NOUN
aiua-6490	18	3	department	department	PROPN
aiua-6490	18	4	suggested	suggest	VERB
aiua-6490	18	5	that	that	SCONJ
aiua-6490	18	6	the	the	DET
aiua-6490	18	7	patients	patient	NOUN
aiua-6490	18	8	’	'	PUNCT
aiua-6490	18	9	symptoms	symptom	NOUN
aiua-6490	18	10	were	be	AUX
aiua-6490	18	11	related	relate	VERB
aiua-6490	18	12	to	to	ADP
aiua-6490	18	13	venlafaxine	venlafaxine	NOUN
aiua-6490	18	14	.	.	PUNCT
aiua-6490	19	1	thus	thus	ADV
aiua-6490	19	2	,	,	PUNCT
aiua-6490	19	3	the	the	DET
aiua-6490	19	4	dose	dose	NOUN
aiua-6490	19	5	of	of	ADP
aiua-6490	19	6	venlafaxine	venlafaxine	NOUN
aiua-6490	19	7	(	(	PUNCT
aiua-6490	19	8	150	150	NUM
aiua-6490	19	9	mg	mg	NOUN
aiua-6490	19	10	/	/	SYM
aiua-6490	19	11	day	day	NOUN
aiua-6490	19	12	)	)	PUNCT
aiua-6490	19	13	was	be	AUX
aiua-6490	19	14	decreased	decrease	VERB
aiua-6490	19	15	gradually	gradually	ADV
aiua-6490	19	16	and	and	CCONJ
aiua-6490	19	17	discontinued	discontinue	VERB
aiua-6490	19	18	after	after	ADP
aiua-6490	19	19	five	five	NUM
aiua-6490	19	20	days	day	NOUN
aiua-6490	19	21	.	.	PUNCT
aiua-6490	20	1	the	the	DET
aiua-6490	20	2	patient	patient	NOUN
aiua-6490	20	3	was	be	AUX
aiua-6490	20	4	prescribed	prescribe	VERB
aiua-6490	20	5	a	a	DET
aiua-6490	20	6	daily	daily	ADJ
aiua-6490	20	7	dose	dose	NOUN
aiua-6490	20	8	(	(	PUNCT
aiua-6490	20	9	25	25	NUM
aiua-6490	20	10	mg	mg	NOUN
aiua-6490	20	11	)	)	PUNCT
aiua-6490	20	12	of	of	ADP
aiua-6490	20	13	agomelatin	agomelatin	PROPN
aiua-6490	20	14	,	,	PUNCT
aiua-6490	20	15	which	which	PRON
aiua-6490	20	16	is	be	AUX
aiua-6490	20	17	a	a	DET
aiua-6490	20	18	melatoninergic	melatoninergic	ADJ
aiua-6490	20	19	receptor	receptor	NOUN
aiua-6490	20	20	agonist	agonist	NOUN
aiua-6490	20	21	antidepressant	antidepressant	NOUN
aiua-6490	20	22	.	.	PUNCT
aiua-6490	21	1	the	the	DET
aiua-6490	21	2	tu	tu	PROPN
aiua-6490	21	3	was	be	AUX
aiua-6490	21	4	removed	remove	VERB
aiua-6490	21	5	one	one	NUM
aiua-6490	21	6	day	day	NOUN
aiua-6490	21	7	after	after	SCONJ
aiua-6490	21	8	the	the	DET
aiua-6490	21	9	dose	dose	NOUN
aiua-6490	21	10	of	of	ADP
aiua-6490	21	11	venlafaxine	venlafaxine	NOUN
aiua-6490	21	12	was	be	AUX
aiua-6490	21	13	decreased	decrease	VERB
aiua-6490	21	14	to	to	ADP
aiua-6490	21	15	37.5	37.5	NUM
aiua-6490	21	16	mg	mg	NOUN
aiua-6490	21	17	twice	twice	DET
aiua-6490	21	18	a	a	DET
aiua-6490	21	19	day	day	NOUN
aiua-6490	21	20	,	,	PUNCT
aiua-6490	21	21	and	and	CCONJ
aiua-6490	21	22	urination	urination	NOUN
aiua-6490	21	23	was	be	AUX
aiua-6490	21	24	monitored	monitor	VERB
aiua-6490	21	25	.	.	PUNCT
aiua-6490	22	1	the	the	DET
aiua-6490	22	2	tu	tu	PROPN
aiua-6490	22	3	was	be	AUX
aiua-6490	22	4	inserted	insert	VERB
aiua-6490	22	5	again	again	ADV
aiua-6490	22	6	when	when	SCONJ
aiua-6490	22	7	the	the	DET
aiua-6490	22	8	patient	patient	NOUN
aiua-6490	22	9	developed	develop	VERB
aiua-6490	22	10	a	a	DET
aiua-6490	22	11	vesical	vesical	ADJ
aiua-6490	22	12	globe	globe	NOUN
aiua-6490	22	13	.	.	PUNCT
aiua-6490	23	1	the	the	DET
aiua-6490	23	2	tu	tu	PROPN
aiua-6490	23	3	catheter	catheter	PROPN
aiua-6490	23	4	was	be	AUX
aiua-6490	23	5	removed	remove	VERB
aiua-6490	23	6	three	three	NUM
aiua-6490	23	7	days	day	NOUN
aiua-6490	23	8	after	after	SCONJ
aiua-6490	23	9	venlafaxine	venlafaxine	NOUN
aiua-6490	23	10	was	be	AUX
aiua-6490	23	11	discontinued	discontinue	VERB
aiua-6490	23	12	.	.	PUNCT
aiua-6490	24	1	during	during	ADP
aiua-6490	24	2	uroflowmetry	uroflowmetry	NOUN
aiua-6490	24	3	,	,	PUNCT
aiua-6490	24	4	the	the	DET
aiua-6490	24	5	patient	patient	NOUN
aiua-6490	24	6	was	be	AUX
aiua-6490	24	7	unable	unable	ADJ
aiua-6490	24	8	to	to	PART
aiua-6490	24	9	urinate	urinate	VERB
aiua-6490	24	10	freely	freely	ADV
aiua-6490	24	11	(	(	PUNCT
aiua-6490	24	12	qmax	qmax	NOUN
aiua-6490	24	13	3	3	NUM
aiua-6490	24	14	ml	ml	NOUN
aiua-6490	24	15	/	/	SYM
aiua-6490	24	16	s	s	NOUN
aiua-6490	24	17	)	)	PUNCT
aiua-6490	24	18	,	,	PUNCT
aiua-6490	24	19	but	but	CCONJ
aiua-6490	24	20	no	no	DET
aiua-6490	24	21	significant	significant	ADJ
aiua-6490	24	22	postvoiding	postvoide	VERB
aiua-6490	24	23	residual	residual	ADJ
aiua-6490	24	24	urine	urine	NOUN
aiua-6490	24	25	(	(	PUNCT
aiua-6490	24	26	pvr	pvr	NOUN
aiua-6490	24	27	)	)	PUNCT
aiua-6490	24	28	was	be	AUX
aiua-6490	24	29	seen	see	VERB
aiua-6490	24	30	in	in	ADP
aiua-6490	24	31	the	the	DET
aiua-6490	24	32	bladder	bladder	NOUN
aiua-6490	24	33	.	.	PUNCT
aiua-6490	25	1	uroflowmetry	uroflowmetry	NOUN
aiua-6490	25	2	was	be	AUX
aiua-6490	25	3	repeated	repeat	VERB
aiua-6490	25	4	the	the	DET
aiua-6490	25	5	next	next	ADJ
aiua-6490	25	6	day	day	NOUN
aiua-6490	25	7	.	.	PUNCT
aiua-6490	26	1	the	the	DET
aiua-6490	26	2	qmax	qmax	PROPN
aiua-6490	26	3	was	be	AUX
aiua-6490	26	4	8.1	8.1	NUM
aiua-6490	26	5	ml	ml	NOUN
aiua-6490	26	6	/	/	SYM
aiua-6490	26	7	s	s	PROPN
aiua-6490	26	8	,	,	PUNCT
aiua-6490	26	9	with	with	ADP
aiua-6490	26	10	no	no	DET
aiua-6490	26	11	significant	significant	ADJ
aiua-6490	26	12	pvr	pvr	NOUN
aiua-6490	26	13	.	.	PUNCT
aiua-6490	27	1	the	the	DET
aiua-6490	27	2	patient	patient	NOUN
aiua-6490	27	3	was	be	AUX
aiua-6490	27	4	discharged	discharge	VERB
aiua-6490	27	5	and	and	CCONJ
aiua-6490	27	6	advised	advise	VERB
aiua-6490	27	7	to	to	PART
aiua-6490	27	8	continue	continue	VERB
aiua-6490	27	9	taking	take	VERB
aiua-6490	27	10	his	his	PRON
aiua-6490	27	11	current	current	ADJ
aiua-6490	27	12	medical	medical	ADJ
aiua-6490	27	13	treatment	treatment	NOUN
aiua-6490	27	14	.	.	PUNCT
aiua-6490	28	1	at	at	ADP
aiua-6490	28	2	outpatient	outpatient	NOUN
aiua-6490	28	3	follow	follow	NOUN
aiua-6490	28	4	-	-	PUNCT
aiua-6490	28	5	up	up	NOUN
aiua-6490	28	6	10	10	NUM
aiua-6490	28	7	days	day	NOUN
aiua-6490	28	8	later	later	ADV
aiua-6490	28	9	,	,	PUNCT
aiua-6490	28	10	the	the	DET
aiua-6490	28	11	symptoms	symptom	NOUN
aiua-6490	28	12	had	have	AUX
aiua-6490	28	13	disappeared	disappear	VERB
aiua-6490	28	14	completely	completely	ADV
aiua-6490	28	15	,	,	PUNCT
aiua-6490	28	16	the	the	DET
aiua-6490	28	17	qmax	qmax	NOUN
aiua-6490	28	18	was	be	AUX
aiua-6490	28	19	19.3	19.3	NUM
aiua-6490	28	20	ml	ml	NOUN
aiua-6490	28	21	/	/	SYM
aiua-6490	28	22	s	s	PROPN
aiua-6490	28	23	,	,	PUNCT
aiua-6490	28	24	and	and	CCONJ
aiua-6490	28	25	the	the	DET
aiua-6490	28	26	pvr	pvr	NOUN
aiua-6490	28	27	was	be	AUX
aiua-6490	28	28	10	10	NUM
aiua-6490	28	29	cc	cc	NOUN
aiua-6490	28	30	on	on	ADP
aiua-6490	28	31	uroflowmetry	uroflowmetry	NOUN
aiua-6490	28	32	.	.	PUNCT
aiua-6490	29	1	discussion	discussion	NOUN
aiua-6490	29	2	venlafaxine	venlafaxine	NOUN
aiua-6490	29	3	belongs	belong	VERB
aiua-6490	29	4	to	to	ADP
aiua-6490	29	5	the	the	DET
aiua-6490	29	6	serotonin	serotonin	NOUN
aiua-6490	29	7	-	-	PUNCT
aiua-6490	29	8	noradrenalin	noradrenalin	NOUN
aiua-6490	29	9	reuptake	reuptake	NOUN
aiua-6490	29	10	inhibitor	inhibitor	NOUN
aiua-6490	29	11	group	group	NOUN
aiua-6490	29	12	and	and	CCONJ
aiua-6490	29	13	exerts	exert	VERB
aiua-6490	29	14	its	its	PRON
aiua-6490	29	15	effects	effect	NOUN
aiua-6490	29	16	by	by	ADP
aiua-6490	29	17	blocking	block	VERB
aiua-6490	29	18	serotonin	serotonin	NOUN
aiua-6490	29	19	,	,	PUNCT
aiua-6490	29	20	noradrenalin	noradrenalin	NOUN
aiua-6490	29	21	and	and	CCONJ
aiua-6490	29	22	,	,	PUNCT
aiua-6490	29	23	at	at	ADP
aiua-6490	29	24	high	high	ADJ
aiua-6490	29	25	doses	dose	NOUN
aiua-6490	29	26	,	,	PUNCT
aiua-6490	29	27	dopamine	dopamine	NOUN
aiua-6490	29	28	uptake	uptake	ADJ
aiua-6490	29	29	bidirectionally	bidirectionally	ADV
aiua-6490	29	30	.	.	PUNCT
aiua-6490	30	1	it	it	PRON
aiua-6490	30	2	is	be	AUX
aiua-6490	30	3	used	use	VERB
aiua-6490	30	4	to	to	PART
aiua-6490	30	5	treat	treat	VERB
aiua-6490	30	6	major	major	ADJ
aiua-6490	30	7	depression	depression	NOUN
aiua-6490	30	8	and	and	CCONJ
aiua-6490	30	9	anxiety	anxiety	NOUN
aiua-6490	30	10	.	.	PUNCT
aiua-6490	31	1	it	it	PRON
aiua-6490	31	2	is	be	AUX
aiua-6490	31	3	administered	administer	VERB
aiua-6490	31	4	orally	orally	ADV
aiua-6490	31	5	and	and	CCONJ
aiua-6490	31	6	is	be	AUX
aiua-6490	31	7	a	a	DET
aiua-6490	31	8	safe	safe	ADJ
aiua-6490	31	9	drug	drug	NOUN
aiua-6490	31	10	that	that	PRON
aiua-6490	31	11	can	can	AUX
aiua-6490	31	12	usually	usually	ADV
aiua-6490	31	13	be	be	AUX
aiua-6490	31	14	tolerated	tolerate	VERB
aiua-6490	31	15	(	(	PUNCT
aiua-6490	31	16	2	2	NUM
aiua-6490	31	17	)	)	PUNCT
aiua-6490	31	18	.	.	PUNCT
aiua-6490	32	1	the	the	DET
aiua-6490	32	2	effects	effect	NOUN
aiua-6490	32	3	of	of	ADP
aiua-6490	32	4	vendoi	vendoi	NOUN
aiua-6490	32	5	:	:	PUNCT
aiua-6490	32	6	10.4081	10.4081	NUM
aiua-6490	32	7	/	/	SYM
aiua-6490	32	8	aiua.2017.2.160	aiua.2017.2.160	NOUN
aiua-6490	32	9	introduction	introduction	NOUN
aiua-6490	32	10	lower	low	ADJ
aiua-6490	32	11	urinary	urinary	ADJ
aiua-6490	32	12	system	system	NOUN
aiua-6490	32	13	symptoms	symptom	NOUN
aiua-6490	32	14	(	(	PUNCT
aiua-6490	32	15	lusss	lusss	NOUN
aiua-6490	32	16	)	)	PUNCT
aiua-6490	32	17	consist	consist	NOUN
aiua-6490	32	18	of	of	ADP
aiua-6490	32	19	symptom	symptom	NOUN
aiua-6490	32	20	subtypes	subtype	NOUN
aiua-6490	32	21	related	relate	VERB
aiua-6490	32	22	to	to	ADP
aiua-6490	32	23	urinary	urinary	ADJ
aiua-6490	32	24	storage	storage	NOUN
aiua-6490	32	25	and	and	CCONJ
aiua-6490	32	26	drainage	drainage	NOUN
aiua-6490	32	27	.	.	PUNCT
aiua-6490	33	1	lusss	lusss	PROPN
aiua-6490	33	2	are	be	AUX
aiua-6490	33	3	an	an	DET
aiua-6490	33	4	important	important	ADJ
aiua-6490	33	5	health	health	NOUN
aiua-6490	33	6	problem	problem	NOUN
aiua-6490	33	7	due	due	ADP
aiua-6490	33	8	to	to	ADP
aiua-6490	33	9	their	their	PRON
aiua-6490	33	10	negative	negative	ADJ
aiua-6490	33	11	effects	effect	NOUN
aiua-6490	33	12	on	on	ADP
aiua-6490	33	13	quality	quality	NOUN
aiua-6490	33	14	of	of	ADP
aiua-6490	33	15	life	life	NOUN
aiua-6490	33	16	.	.	PUNCT
aiua-6490	34	1	acute	acute	ADJ
aiua-6490	34	2	urinary	urinary	ADJ
aiua-6490	34	3	retention	retention	NOUN
aiua-6490	34	4	develops	develop	VERB
aiua-6490	34	5	due	due	ADJ
aiua-6490	34	6	to	to	ADP
aiua-6490	34	7	an	an	DET
aiua-6490	34	8	inability	inability	NOUN
aiua-6490	34	9	to	to	PART
aiua-6490	34	10	urinate	urinate	VERB
aiua-6490	34	11	and	and	CCONJ
aiua-6490	34	12	results	result	NOUN
aiua-6490	34	13	in	in	ADP
aiua-6490	34	14	a	a	DET
aiua-6490	34	15	full	full	ADJ
aiua-6490	34	16	and	and	CCONJ
aiua-6490	34	17	tense	tense	ADJ
aiua-6490	34	18	bladder	bladder	NOUN
aiua-6490	34	19	,	,	PUNCT
aiua-6490	34	20	together	together	ADV
aiua-6490	34	21	with	with	ADP
aiua-6490	34	22	suprapubic	suprapubic	ADJ
aiua-6490	34	23	pain	pain	NOUN
aiua-6490	34	24	and	and	CCONJ
aiua-6490	34	25	tenderness	tenderness	NOUN
aiua-6490	34	26	.	.	PUNCT
aiua-6490	35	1	the	the	DET
aiua-6490	35	2	most	most	ADV
aiua-6490	35	3	common	common	ADJ
aiua-6490	35	4	cause	cause	NOUN
aiua-6490	35	5	of	of	ADP
aiua-6490	35	6	lusss	lusss	NOUN
aiua-6490	35	7	is	be	AUX
aiua-6490	35	8	benign	benign	ADJ
aiua-6490	35	9	prostate	prostate	NOUN
aiua-6490	35	10	hyperplasia	hyperplasia	NOUN
aiua-6490	35	11	.	.	PUNCT
aiua-6490	36	1	acute	acute	ADJ
aiua-6490	36	2	urinary	urinary	ADJ
aiua-6490	36	3	retention	retention	NOUN
aiua-6490	36	4	can	can	AUX
aiua-6490	36	5	develop	develop	VERB
aiua-6490	36	6	due	due	ADJ
aiua-6490	36	7	to	to	ADP
aiua-6490	36	8	genitourinary	genitourinary	ADJ
aiua-6490	36	9	system	system	NOUN
aiua-6490	36	10	tumors	tumor	NOUN
aiua-6490	36	11	,	,	PUNCT
aiua-6490	36	12	vesical	vesical	ADJ
aiua-6490	36	13	or	or	CCONJ
aiua-6490	36	14	urethral	urethral	ADJ
aiua-6490	36	15	stones	stone	NOUN
aiua-6490	36	16	,	,	PUNCT
aiua-6490	36	17	urethral	urethral	ADJ
aiua-6490	36	18	strictures	stricture	NOUN
aiua-6490	36	19	,	,	PUNCT
aiua-6490	36	20	and	and	CCONJ
aiua-6490	36	21	medications	medication	NOUN
aiua-6490	36	22	,	,	PUNCT
aiua-6490	36	23	in	in	ADP
aiua-6490	36	24	addition	addition	NOUN
aiua-6490	36	25	to	to	ADP
aiua-6490	36	26	acute	acute	VERB
aiua-6490	36	27	prostatitis	prostatitis	NOUN
aiua-6490	36	28	and	and	CCONJ
aiua-6490	36	29	neurological	neurological	ADJ
aiua-6490	36	30	diseases	disease	NOUN
aiua-6490	36	31	(	(	PUNCT
aiua-6490	36	32	1	1	NUM
aiua-6490	36	33	)	)	PUNCT
aiua-6490	36	34	.	.	PUNCT
aiua-6490	37	1	several	several	ADJ
aiua-6490	37	2	case	case	NOUN
aiua-6490	37	3	reports	report	NOUN
aiua-6490	37	4	have	have	AUX
aiua-6490	37	5	described	describe	VERB
aiua-6490	37	6	venlafaxine	venlafaxine	NOUN
aiua-6490	37	7	-	-	PUNCT
aiua-6490	37	8	related	relate	VERB
aiua-6490	37	9	acute	acute	ADJ
aiua-6490	37	10	urinary	urinary	ADJ
aiua-6490	37	11	retention	retention	NOUN
aiua-6490	37	12	when	when	SCONJ
aiua-6490	37	13	the	the	DET
aiua-6490	37	14	drug	drug	NOUN
aiua-6490	37	15	was	be	AUX
aiua-6490	37	16	used	use	VERB
aiua-6490	37	17	in	in	ADP
aiua-6490	37	18	combination	combination	NOUN
aiua-6490	37	19	and	and	CCONJ
aiua-6490	37	20	in	in	ADP
aiua-6490	37	21	high	high	ADJ
aiua-6490	37	22	doses.we	doses.we	X
aiua-6490	37	23	describe	describe	VERB
aiua-6490	37	24	a	a	DET
aiua-6490	37	25	case	case	NOUN
aiua-6490	37	26	of	of	ADP
aiua-6490	37	27	lusss	lusss	NOUN
aiua-6490	37	28	and	and	CCONJ
aiua-6490	37	29	acute	acute	ADJ
aiua-6490	37	30	urinary	urinary	ADJ
aiua-6490	37	31	retention	retention	NOUN
aiua-6490	37	32	that	that	PRON
aiua-6490	37	33	developed	develop	VERB
aiua-6490	37	34	following	follow	VERB
aiua-6490	37	35	the	the	DET
aiua-6490	37	36	use	use	NOUN
aiua-6490	37	37	of	of	ADP
aiua-6490	37	38	low	low	ADJ
aiua-6490	37	39	-	-	PUNCT
aiua-6490	37	40	dose	dose	NOUN
aiua-6490	37	41	venlafaxine	venlafaxine	NOUN
aiua-6490	37	42	monotherapy	monotherapy	NOUN
aiua-6490	37	43	.	.	PUNCT
aiua-6490	38	1	case	case	NOUN
aiua-6490	38	2	report	report	VERB
aiua-6490	38	3	a	a	DET
aiua-6490	38	4	48	48	NUM
aiua-6490	38	5	-	-	PUNCT
aiua-6490	38	6	year	year	NOUN
aiua-6490	38	7	-	-	PUNCT
aiua-6490	38	8	old	old	ADJ
aiua-6490	38	9	male	male	ADJ
aiua-6490	38	10	patient	patient	NOUN
aiua-6490	38	11	with	with	ADP
aiua-6490	38	12	a	a	DET
aiua-6490	38	13	diagnosis	diagnosis	NOUN
aiua-6490	38	14	of	of	ADP
aiua-6490	38	15	major	major	ADJ
aiua-6490	38	16	depression	depression	NOUN
aiua-6490	38	17	presented	present	VERB
aiua-6490	38	18	to	to	ADP
aiua-6490	38	19	our	our	PRON
aiua-6490	38	20	clinic	clinic	NOUN
aiua-6490	38	21	with	with	ADP
aiua-6490	38	22	lusss	lusss	NOUN
aiua-6490	38	23	,	,	PUNCT
aiua-6490	38	24	which	which	PRON
aiua-6490	38	25	included	include	VERB
aiua-6490	38	26	difficulty	difficulty	NOUN
aiua-6490	38	27	urinating	urinate	VERB
aiua-6490	38	28	,	,	PUNCT
aiua-6490	38	29	an	an	DET
aiua-6490	38	30	intermittent	intermittent	ADJ
aiua-6490	38	31	stream	stream	NOUN
aiua-6490	38	32	,	,	PUNCT
aiua-6490	38	33	and	and	CCONJ
aiua-6490	38	34	trickling	trickle	VERB
aiua-6490	38	35	at	at	ADP
aiua-6490	38	36	the	the	DET
aiua-6490	38	37	end	end	NOUN
aiua-6490	38	38	of	of	ADP
aiua-6490	38	39	urination	urination	NOUN
aiua-6490	38	40	,	,	PUNCT
aiua-6490	38	41	together	together	ADV
aiua-6490	38	42	with	with	ADP
aiua-6490	38	43	an	an	DET
aiua-6490	38	44	inability	inability	NOUN
aiua-6490	38	45	to	to	PART
aiua-6490	38	46	urinate	urinate	VERB
aiua-6490	38	47	.	.	PUNCT
aiua-6490	39	1	the	the	DET
aiua-6490	39	2	symptoms	symptom	NOUN
aiua-6490	39	3	had	have	AUX
aiua-6490	39	4	lasted	last	VERB
aiua-6490	39	5	for	for	ADP
aiua-6490	39	6	about	about	ADV
aiua-6490	39	7	20	20	NUM
aiua-6490	39	8	h	h	NOUN
aiua-6490	39	9	demridogen_stesura	demridogen_stesura	NOUN
aiua-6490	39	10	seveso	seveso	VERB
aiua-6490	39	11	20/06/17	20/06/17	PROPN
aiua-6490	39	12	10:04	10:04	NUM
aiua-6490	39	13	pagina	pagina	NOUN
aiua-6490	39	14	160	160	NUM
aiua-6490	39	15	161archivio	161archivio	PROPN
aiua-6490	39	16	italiano	italiano	NOUN
aiua-6490	39	17	di	di	X
aiua-6490	39	18	urologia	urologia	PROPN
aiua-6490	39	19	e	e	PROPN
aiua-6490	39	20	andrologia	andrologia	NOUN
aiua-6490	39	21	2017	2017	NUM
aiua-6490	39	22	;	;	PUNCT
aiua-6490	39	23	89	89	NUM
aiua-6490	39	24	,	,	PUNCT
aiua-6490	39	25	2	2	NUM
aiua-6490	39	26	urinary	urinary	ADJ
aiua-6490	39	27	retention	retention	NOUN
aiua-6490	39	28	and	and	CCONJ
aiua-6490	39	29	venlafaxine	venlafaxine	ADJ
aiua-6490	39	30	lafaxine	lafaxine	NOUN
aiua-6490	39	31	are	be	AUX
aiua-6490	39	32	similar	similar	ADJ
aiua-6490	39	33	to	to	ADP
aiua-6490	39	34	those	those	PRON
aiua-6490	39	35	of	of	ADP
aiua-6490	39	36	tricyclic	tricyclic	ADJ
aiua-6490	39	37	antidepressants	antidepressant	NOUN
aiua-6490	39	38	,	,	PUNCT
aiua-6490	39	39	which	which	PRON
aiua-6490	39	40	also	also	ADV
aiua-6490	39	41	affect	affect	VERB
aiua-6490	39	42	serotonin	serotonin	NOUN
aiua-6490	39	43	and	and	CCONJ
aiua-6490	39	44	noradrenalin	noradrenalin	NOUN
aiua-6490	39	45	receptors	receptor	NOUN
aiua-6490	39	46	,	,	PUNCT
aiua-6490	39	47	but	but	CCONJ
aiua-6490	39	48	it	it	PRON
aiua-6490	39	49	has	have	VERB
aiua-6490	39	50	relatively	relatively	ADV
aiua-6490	39	51	few	few	ADJ
aiua-6490	39	52	side	side	NOUN
aiua-6490	39	53	effects	effect	NOUN
aiua-6490	39	54	due	due	ADJ
aiua-6490	39	55	to	to	ADP
aiua-6490	39	56	its	its	PRON
aiua-6490	39	57	lack	lack	NOUN
aiua-6490	39	58	of	of	ADP
aiua-6490	39	59	affinity	affinity	NOUN
aiua-6490	39	60	to	to	ADP
aiua-6490	39	61	other	other	ADJ
aiua-6490	39	62	receptors	receptor	NOUN
aiua-6490	39	63	.	.	PUNCT
aiua-6490	40	1	the	the	DET
aiua-6490	40	2	most	most	ADV
aiua-6490	40	3	common	common	ADJ
aiua-6490	40	4	side	side	NOUN
aiua-6490	40	5	effects	effect	NOUN
aiua-6490	40	6	are	be	AUX
aiua-6490	40	7	nausea	nausea	NOUN
aiua-6490	40	8	,	,	PUNCT
aiua-6490	40	9	somnolence	somnolence	NOUN
aiua-6490	40	10	,	,	PUNCT
aiua-6490	40	11	dry	dry	ADJ
aiua-6490	40	12	mouth	mouth	NOUN
aiua-6490	40	13	,	,	PUNCT
aiua-6490	40	14	dizziness	dizziness	NOUN
aiua-6490	40	15	,	,	PUNCT
aiua-6490	40	16	irritability	irritability	NOUN
aiua-6490	40	17	,	,	PUNCT
aiua-6490	40	18	constipation	constipation	NOUN
aiua-6490	40	19	,	,	PUNCT
aiua-6490	40	20	asthenia	asthenia	PROPN
aiua-6490	40	21	,	,	PUNCT
aiua-6490	40	22	anxiety	anxiety	NOUN
aiua-6490	40	23	,	,	PUNCT
aiua-6490	40	24	anorexia	anorexia	ADJ
aiua-6490	40	25	,	,	PUNCT
aiua-6490	40	26	blurred	blurred	ADJ
aiua-6490	40	27	vision	vision	NOUN
aiua-6490	40	28	,	,	PUNCT
aiua-6490	40	29	abnormal	abnormal	ADJ
aiua-6490	40	30	ejaculation	ejaculation	NOUN
aiua-6490	40	31	or	or	CCONJ
aiua-6490	40	32	orgasm	orgasm	NOUN
aiua-6490	40	33	,	,	PUNCT
aiua-6490	40	34	and	and	CCONJ
aiua-6490	40	35	impotence	impotence	NOUN
aiua-6490	40	36	.	.	PUNCT
aiua-6490	41	1	however	however	ADV
aiua-6490	41	2	,	,	PUNCT
aiua-6490	41	3	these	these	DET
aiua-6490	41	4	effects	effect	NOUN
aiua-6490	41	5	are	be	AUX
aiua-6490	41	6	usually	usually	ADV
aiua-6490	41	7	mild	mild	ADJ
aiua-6490	41	8	and	and	CCONJ
aiua-6490	41	9	rarely	rarely	ADV
aiua-6490	41	10	require	require	VERB
aiua-6490	41	11	treatment	treatment	NOUN
aiua-6490	41	12	cessation	cessation	NOUN
aiua-6490	41	13	.	.	PUNCT
aiua-6490	42	1	in	in	ADP
aiua-6490	42	2	addition	addition	NOUN
aiua-6490	42	3	to	to	ADP
aiua-6490	42	4	the	the	DET
aiua-6490	42	5	above	above	ADV
aiua-6490	42	6	-	-	PUNCT
aiua-6490	42	7	mentioned	mention	VERB
aiua-6490	42	8	side	side	NOUN
aiua-6490	42	9	effects	effect	NOUN
aiua-6490	42	10	,	,	PUNCT
aiua-6490	42	11	hypertension	hypertension	NOUN
aiua-6490	42	12	was	be	AUX
aiua-6490	42	13	reported	report	VERB
aiua-6490	42	14	to	to	PART
aiua-6490	42	15	be	be	AUX
aiua-6490	42	16	a	a	DET
aiua-6490	42	17	common	common	ADJ
aiua-6490	42	18	problem	problem	NOUN
aiua-6490	42	19	among	among	ADP
aiua-6490	42	20	patients	patient	NOUN
aiua-6490	42	21	taking	take	VERB
aiua-6490	42	22	venlafaxine	venlafaxine	NOUN
aiua-6490	42	23	(	(	PUNCT
aiua-6490	42	24	3	3	NUM
aiua-6490	42	25	)	)	PUNCT
aiua-6490	42	26	.	.	PUNCT
aiua-6490	43	1	due	due	ADP
aiua-6490	43	2	to	to	ADP
aiua-6490	43	3	its	its	PRON
aiua-6490	43	4	tolerability	tolerability	NOUN
aiua-6490	43	5	and	and	CCONJ
aiua-6490	43	6	few	few	ADJ
aiua-6490	43	7	side	side	NOUN
aiua-6490	43	8	effects	effect	NOUN
aiua-6490	43	9	mentioned	mention	VERB
aiua-6490	43	10	above	above	ADV
aiua-6490	43	11	,	,	PUNCT
aiua-6490	43	12	venlafaxine	venlafaxine	NOUN
aiua-6490	43	13	is	be	AUX
aiua-6490	43	14	considered	consider	VERB
aiua-6490	43	15	a	a	DET
aiua-6490	43	16	good	good	ADJ
aiua-6490	43	17	option	option	NOUN
aiua-6490	43	18	for	for	ADP
aiua-6490	43	19	patients	patient	NOUN
aiua-6490	43	20	with	with	ADP
aiua-6490	43	21	major	major	ADJ
aiua-6490	43	22	depression	depression	NOUN
aiua-6490	43	23	.	.	PUNCT
aiua-6490	44	1	lusss	lusss	VERB
aiua-6490	44	2	and	and	CCONJ
aiua-6490	44	3	acute	acute	ADJ
aiua-6490	44	4	urinary	urinary	ADJ
aiua-6490	44	5	retention	retention	NOUN
aiua-6490	44	6	can	can	AUX
aiua-6490	44	7	occur	occur	VERB
aiua-6490	44	8	following	follow	VERB
aiua-6490	44	9	the	the	DET
aiua-6490	44	10	use	use	NOUN
aiua-6490	44	11	of	of	ADP
aiua-6490	44	12	opiates	opiate	NOUN
aiua-6490	44	13	,	,	PUNCT
aiua-6490	44	14	antihistamines	antihistamine	NOUN
aiua-6490	44	15	,	,	PUNCT
aiua-6490	44	16	alpha	alpha	ADJ
aiua-6490	44	17	adrenergic	adrenergic	ADJ
aiua-6490	44	18	agonists	agonist	NOUN
aiua-6490	44	19	,	,	PUNCT
aiua-6490	44	20	ganglion	ganglion	NOUN
aiua-6490	44	21	blockers	blocker	NOUN
aiua-6490	44	22	,	,	PUNCT
aiua-6490	44	23	phenothiazines	phenothiazine	NOUN
aiua-6490	44	24	,	,	PUNCT
aiua-6490	44	25	and	and	CCONJ
aiua-6490	44	26	monoamino	monoamino	NOUN
aiua-6490	44	27	oxidase	oxidase	NOUN
aiua-6490	44	28	(	(	PUNCT
aiua-6490	44	29	mao	mao	NOUN
aiua-6490	44	30	)	)	PUNCT
aiua-6490	44	31	inhibitors	inhibitor	NOUN
aiua-6490	44	32	.	.	PUNCT
aiua-6490	45	1	these	these	DET
aiua-6490	45	2	findings	finding	NOUN
aiua-6490	45	3	are	be	AUX
aiua-6490	45	4	attributed	attribute	VERB
aiua-6490	45	5	to	to	ADP
aiua-6490	45	6	the	the	DET
aiua-6490	45	7	contraction	contraction	NOUN
aiua-6490	45	8	of	of	ADP
aiua-6490	45	9	the	the	DET
aiua-6490	45	10	urethral	urethral	ADJ
aiua-6490	45	11	sphincter	sphincter	ADJ
aiua-6490	45	12	muscle	muscle	NOUN
aiua-6490	45	13	as	as	ADP
aiua-6490	45	14	a	a	DET
aiua-6490	45	15	result	result	NOUN
aiua-6490	45	16	of	of	ADP
aiua-6490	45	17	anticholinergic	anticholinergic	ADJ
aiua-6490	45	18	stimulation	stimulation	NOUN
aiua-6490	45	19	(	(	PUNCT
aiua-6490	45	20	4	4	NUM
aiua-6490	45	21	)	)	PUNCT
aiua-6490	45	22	.	.	PUNCT
aiua-6490	46	1	previous	previous	ADJ
aiua-6490	46	2	studies	study	NOUN
aiua-6490	46	3	also	also	ADV
aiua-6490	46	4	showed	show	VERB
aiua-6490	46	5	that	that	SCONJ
aiua-6490	46	6	lusss	lusss	NOUN
aiua-6490	46	7	and	and	CCONJ
aiua-6490	46	8	acute	acute	ADJ
aiua-6490	46	9	urinary	urinary	ADJ
aiua-6490	46	10	retention	retention	NOUN
aiua-6490	46	11	developed	develop	VERB
aiua-6490	46	12	following	follow	VERB
aiua-6490	46	13	treatment	treatment	NOUN
aiua-6490	46	14	with	with	ADP
aiua-6490	46	15	antidepressant	antidepressant	ADJ
aiua-6490	46	16	and	and	CCONJ
aiua-6490	46	17	antipsychotic	antipsychotic	ADJ
aiua-6490	46	18	drugs	drug	NOUN
aiua-6490	46	19	.	.	PUNCT
aiua-6490	47	1	the	the	DET
aiua-6490	47	2	development	development	NOUN
aiua-6490	47	3	of	of	ADP
aiua-6490	47	4	lusss	lusss	NOUN
aiua-6490	47	5	was	be	AUX
aiua-6490	47	6	reported	report	VERB
aiua-6490	47	7	after	after	ADP
aiua-6490	47	8	the	the	DET
aiua-6490	47	9	use	use	NOUN
aiua-6490	47	10	of	of	ADP
aiua-6490	47	11	duloxetine	duloxetine	NOUN
aiua-6490	47	12	,	,	PUNCT
aiua-6490	47	13	a	a	DET
aiua-6490	47	14	selective	selective	ADJ
aiua-6490	47	15	serotonin	serotonin	NOUN
aiua-6490	47	16	noradrenalin	noradrenalin	NOUN
aiua-6490	47	17	reuptake	reuptake	NOUN
aiua-6490	47	18	inhibitor	inhibitor	NOUN
aiua-6490	47	19	(	(	PUNCT
aiua-6490	47	20	5	5	NUM
aiua-6490	47	21	)	)	PUNCT
aiua-6490	47	22	and	and	CCONJ
aiua-6490	47	23	milnasipram	milnasipram	NOUN
aiua-6490	47	24	,	,	PUNCT
aiua-6490	47	25	another	another	DET
aiua-6490	47	26	antidepressant	antidepressant	NOUN
aiua-6490	47	27	(	(	PUNCT
aiua-6490	47	28	6	6	NUM
aiua-6490	47	29	)	)	PUNCT
aiua-6490	47	30	.	.	PUNCT
aiua-6490	48	1	urinary	urinary	ADJ
aiua-6490	48	2	side	side	NOUN
aiua-6490	48	3	effects	effect	NOUN
aiua-6490	48	4	,	,	PUNCT
aiua-6490	48	5	such	such	ADJ
aiua-6490	48	6	as	as	ADP
aiua-6490	48	7	urinary	urinary	ADJ
aiua-6490	48	8	incontinence	incontinence	NOUN
aiua-6490	48	9	,	,	PUNCT
aiua-6490	48	10	related	relate	VERB
aiua-6490	48	11	to	to	ADP
aiua-6490	48	12	venlafaxine	venlafaxine	NOUN
aiua-6490	48	13	have	have	AUX
aiua-6490	48	14	previously	previously	ADV
aiua-6490	48	15	been	be	AUX
aiua-6490	48	16	reported	report	VERB
aiua-6490	48	17	in	in	ADP
aiua-6490	48	18	the	the	DET
aiua-6490	48	19	literature	literature	NOUN
aiua-6490	48	20	(	(	PUNCT
aiua-6490	48	21	7	7	NUM
aiua-6490	48	22	,	,	PUNCT
aiua-6490	48	23	8)	8)	NUM
aiua-6490	48	24	,	,	PUNCT
aiua-6490	48	25	and	and	CCONJ
aiua-6490	48	26	several	several	ADJ
aiua-6490	48	27	cases	case	NOUN
aiua-6490	48	28	of	of	ADP
aiua-6490	48	29	lusss	lusss	NOUN
aiua-6490	48	30	and	and	CCONJ
aiua-6490	48	31	acute	acute	ADJ
aiua-6490	48	32	urinary	urinary	ADJ
aiua-6490	48	33	retention	retention	NOUN
aiua-6490	48	34	following	follow	VERB
aiua-6490	48	35	the	the	DET
aiua-6490	48	36	use	use	NOUN
aiua-6490	48	37	of	of	ADP
aiua-6490	48	38	venlafaxine	venlafaxine	NOUN
aiua-6490	48	39	were	be	AUX
aiua-6490	48	40	reported	report	VERB
aiua-6490	48	41	.	.	PUNCT
aiua-6490	49	1	however	however	ADV
aiua-6490	49	2	,	,	PUNCT
aiua-6490	49	3	these	these	DET
aiua-6490	49	4	side	side	NOUN
aiua-6490	49	5	effects	effect	NOUN
aiua-6490	49	6	only	only	ADV
aiua-6490	49	7	occurred	occur	VERB
aiua-6490	49	8	when	when	SCONJ
aiua-6490	49	9	venlafaxine	venlafaxine	NOUN
aiua-6490	49	10	was	be	AUX
aiua-6490	49	11	used	use	VERB
aiua-6490	49	12	in	in	ADP
aiua-6490	49	13	combination	combination	NOUN
aiua-6490	49	14	with	with	ADP
aiua-6490	49	15	another	another	DET
aiua-6490	49	16	drug	drug	NOUN
aiua-6490	49	17	or	or	CCONJ
aiua-6490	49	18	when	when	SCONJ
aiua-6490	49	19	venlafaxine	venlafaxine	NOUN
aiua-6490	49	20	was	be	AUX
aiua-6490	49	21	administered	administer	VERB
aiua-6490	49	22	at	at	ADP
aiua-6490	49	23	high	high	ADJ
aiua-6490	49	24	doses	dose	NOUN
aiua-6490	49	25	(	(	PUNCT
aiua-6490	49	26	375	375	NUM
aiua-6490	49	27	mg	mg	ADV
aiua-6490	49	28	once	once	ADV
aiua-6490	49	29	daily	daily	ADV
aiua-6490	49	30	)	)	PUNCT
aiua-6490	49	31	when	when	SCONJ
aiua-6490	49	32	used	use	VERB
aiua-6490	49	33	as	as	ADP
aiua-6490	49	34	monotherapy	monotherapy	NOUN
aiua-6490	49	35	(	(	PUNCT
aiua-6490	49	36	9	9	NUM
aiua-6490	49	37	,	,	PUNCT
aiua-6490	49	38	10	10	NUM
aiua-6490	49	39	)	)	PUNCT
aiua-6490	49	40	.	.	PUNCT
aiua-6490	50	1	our	our	PRON
aiua-6490	50	2	case	case	NOUN
aiua-6490	50	3	is	be	AUX
aiua-6490	50	4	important	important	ADJ
aiua-6490	50	5	,	,	PUNCT
aiua-6490	50	6	as	as	SCONJ
aiua-6490	50	7	it	it	PRON
aiua-6490	50	8	is	be	AUX
aiua-6490	50	9	the	the	DET
aiua-6490	50	10	first	first	ADJ
aiua-6490	50	11	report	report	NOUN
aiua-6490	50	12	of	of	ADP
aiua-6490	50	13	the	the	DET
aiua-6490	50	14	development	development	NOUN
aiua-6490	50	15	of	of	ADP
aiua-6490	50	16	lusss	lusss	NOUN
aiua-6490	50	17	and	and	CCONJ
aiua-6490	50	18	acute	acute	ADJ
aiua-6490	50	19	urinary	urinary	ADJ
aiua-6490	50	20	retention	retention	NOUN
aiua-6490	50	21	when	when	SCONJ
aiua-6490	50	22	venlafaxine	venlafaxine	NOUN
aiua-6490	50	23	was	be	AUX
aiua-6490	50	24	used	use	VERB
aiua-6490	50	25	as	as	ADP
aiua-6490	50	26	monotherapy	monotherapy	NOUN
aiua-6490	50	27	and	and	CCONJ
aiua-6490	50	28	at	at	ADP
aiua-6490	50	29	a	a	DET
aiua-6490	50	30	low	low	ADJ
aiua-6490	50	31	dose	dose	NOUN
aiua-6490	50	32	.	.	PUNCT
aiua-6490	51	1	lusss	lusss	PROPN
aiua-6490	51	2	and	and	CCONJ
aiua-6490	51	3	acute	acute	ADJ
aiua-6490	51	4	urinary	urinary	ADJ
aiua-6490	51	5	retention	retention	NOUN
aiua-6490	51	6	are	be	AUX
aiua-6490	51	7	thought	think	VERB
aiua-6490	51	8	to	to	PART
aiua-6490	51	9	be	be	AUX
aiua-6490	51	10	due	due	ADJ
aiua-6490	51	11	to	to	ADP
aiua-6490	51	12	adrenergic	adrenergic	ADJ
aiua-6490	51	13	stimulation	stimulation	NOUN
aiua-6490	51	14	,	,	PUNCT
aiua-6490	51	15	which	which	PRON
aiua-6490	51	16	occurs	occur	VERB
aiua-6490	51	17	as	as	ADP
aiua-6490	51	18	a	a	DET
aiua-6490	51	19	result	result	NOUN
aiua-6490	51	20	of	of	ADP
aiua-6490	51	21	venlafaxine	venlafaxine	NOUN
aiua-6490	51	22	inhibiting	inhibit	VERB
aiua-6490	51	23	noradrenaline	noradrenaline	ADJ
aiua-6490	51	24	reuptake	reuptake	NOUN
aiua-6490	51	25	.	.	PUNCT
aiua-6490	52	1	these	these	DET
aiua-6490	52	2	side	side	NOUN
aiua-6490	52	3	effects	effect	NOUN
aiua-6490	52	4	can	can	AUX
aiua-6490	52	5	be	be	AUX
aiua-6490	52	6	severe	severe	ADJ
aiua-6490	52	7	and	and	CCONJ
aiua-6490	52	8	can	can	AUX
aiua-6490	52	9	interfere	interfere	VERB
aiua-6490	52	10	with	with	ADP
aiua-6490	52	11	the	the	DET
aiua-6490	52	12	continuation	continuation	NOUN
aiua-6490	52	13	of	of	ADP
aiua-6490	52	14	treatment	treatment	NOUN
aiua-6490	52	15	,	,	PUNCT
aiua-6490	52	16	as	as	ADP
aiua-6490	52	17	in	in	ADP
aiua-6490	52	18	the	the	DET
aiua-6490	52	19	present	present	ADJ
aiua-6490	52	20	case	case	NOUN
aiua-6490	52	21	.	.	PUNCT
aiua-6490	53	1	despite	despite	SCONJ
aiua-6490	53	2	these	these	DET
aiua-6490	53	3	side	side	NOUN
aiua-6490	53	4	effects	effect	NOUN
aiua-6490	53	5	,	,	PUNCT
aiua-6490	53	6	in	in	ADP
aiua-6490	53	7	a	a	DET
aiua-6490	53	8	limited	limited	ADJ
aiua-6490	53	9	patient	patient	NOUN
aiua-6490	53	10	series	series	NOUN
aiua-6490	53	11	,	,	PUNCT
aiua-6490	53	12	venlafaxine	venlafaxine	NOUN
aiua-6490	53	13	was	be	AUX
aiua-6490	53	14	reported	report	VERB
aiua-6490	53	15	to	to	PART
aiua-6490	53	16	increase	increase	VERB
aiua-6490	53	17	the	the	DET
aiua-6490	53	18	quality	quality	NOUN
aiua-6490	53	19	of	of	ADP
aiua-6490	53	20	life	life	NOUN
aiua-6490	53	21	of	of	ADP
aiua-6490	53	22	patients	patient	NOUN
aiua-6490	53	23	with	with	ADP
aiua-6490	53	24	neurological	neurological	ADJ
aiua-6490	53	25	disorders	disorder	NOUN
aiua-6490	53	26	by	by	ADP
aiua-6490	53	27	reducing	reduce	VERB
aiua-6490	53	28	their	their	PRON
aiua-6490	53	29	daily	daily	ADJ
aiua-6490	53	30	urination	urination	NOUN
aiua-6490	53	31	frequency	frequency	NOUN
aiua-6490	53	32	and	and	CCONJ
aiua-6490	53	33	increasing	increase	VERB
aiua-6490	53	34	their	their	PRON
aiua-6490	53	35	bladder	bladder	NOUN
aiua-6490	53	36	capacity	capacity	NOUN
aiua-6490	53	37	(	(	PUNCT
aiua-6490	53	38	11	11	NUM
aiua-6490	53	39	)	)	PUNCT
aiua-6490	53	40	.	.	PUNCT
aiua-6490	54	1	in	in	ADP
aiua-6490	54	2	the	the	DET
aiua-6490	54	3	present	present	ADJ
aiua-6490	54	4	case	case	NOUN
aiua-6490	54	5	,	,	PUNCT
aiua-6490	54	6	agomelatine	agomelatine	NOUN
aiua-6490	54	7	,	,	PUNCT
aiua-6490	54	8	which	which	PRON
aiua-6490	54	9	is	be	AUX
aiua-6490	54	10	used	use	VERB
aiua-6490	54	11	to	to	PART
aiua-6490	54	12	treat	treat	VERB
aiua-6490	54	13	depression	depression	NOUN
aiua-6490	54	14	and	and	CCONJ
aiua-6490	54	15	sleep	sleep	NOUN
aiua-6490	54	16	disorders	disorder	NOUN
aiua-6490	54	17	,	,	PUNCT
aiua-6490	54	18	was	be	AUX
aiua-6490	54	19	thought	think	VERB
aiua-6490	54	20	to	to	PART
aiua-6490	54	21	be	be	AUX
aiua-6490	54	22	a	a	DET
aiua-6490	54	23	safer	safe	ADJ
aiua-6490	54	24	option	option	NOUN
aiua-6490	54	25	than	than	ADP
aiua-6490	54	26	venlafaxine	venlafaxine	NOUN
aiua-6490	54	27	due	due	ADP
aiua-6490	54	28	to	to	ADP
aiua-6490	54	29	its	its	PRON
aiua-6490	54	30	lack	lack	NOUN
aiua-6490	54	31	of	of	ADP
aiua-6490	54	32	interaction	interaction	NOUN
aiua-6490	54	33	with	with	ADP
aiua-6490	54	34	the	the	DET
aiua-6490	54	35	relevant	relevant	ADJ
aiua-6490	54	36	receptors	receptor	NOUN
aiua-6490	54	37	and	and	CCONJ
aiua-6490	54	38	the	the	DET
aiua-6490	54	39	patient	patient	NOUN
aiua-6490	54	40	’s	’s	PART
aiua-6490	54	41	clinical	clinical	ADJ
aiua-6490	54	42	condition	condition	NOUN
aiua-6490	54	43	,	,	PUNCT
aiua-6490	54	44	and	and	CCONJ
aiua-6490	54	45	no	no	DET
aiua-6490	54	46	urinary	urinary	ADJ
aiua-6490	54	47	tract	tract	NOUN
aiua-6490	54	48	side	side	NOUN
aiua-6490	54	49	effects	effect	NOUN
aiua-6490	54	50	were	be	AUX
aiua-6490	54	51	observed	observe	VERB
aiua-6490	54	52	.	.	PUNCT
aiua-6490	55	1	conclusion	conclusion	NOUN
aiua-6490	55	2	venlafaxine	venlafaxine	NOUN
aiua-6490	55	3	is	be	AUX
aiua-6490	55	4	a	a	DET
aiua-6490	55	5	safe	safe	ADJ
aiua-6490	55	6	and	and	CCONJ
aiua-6490	55	7	effective	effective	ADJ
aiua-6490	55	8	antidepressant	antidepressant	NOUN
aiua-6490	55	9	for	for	ADP
aiua-6490	55	10	the	the	DET
aiua-6490	55	11	treatment	treatment	NOUN
aiua-6490	55	12	of	of	ADP
aiua-6490	55	13	major	major	ADJ
aiua-6490	55	14	depression	depression	NOUN
aiua-6490	55	15	and	and	CCONJ
aiua-6490	55	16	anxiety	anxiety	NOUN
aiua-6490	55	17	disorders	disorder	NOUN
aiua-6490	55	18	.	.	PUNCT
aiua-6490	56	1	however	however	ADV
aiua-6490	56	2	,	,	PUNCT
aiua-6490	56	3	it	it	PRON
aiua-6490	56	4	may	may	AUX
aiua-6490	56	5	not	not	PART
aiua-6490	56	6	be	be	AUX
aiua-6490	56	7	suitable	suitable	ADJ
aiua-6490	56	8	for	for	ADP
aiua-6490	56	9	patients	patient	NOUN
aiua-6490	56	10	with	with	ADP
aiua-6490	56	11	accompanying	accompany	VERB
aiua-6490	56	12	prostate	prostate	NOUN
aiua-6490	56	13	disease	disease	NOUN
aiua-6490	56	14	or	or	CCONJ
aiua-6490	56	15	micturition	micturition	NOUN
aiua-6490	56	16	disorders	disorder	NOUN
aiua-6490	56	17	.	.	PUNCT
aiua-6490	57	1	prior	prior	ADV
aiua-6490	57	2	to	to	ADP
aiua-6490	57	3	prescribing	prescribe	VERB
aiua-6490	57	4	venlafaxine	venlafaxine	NOUN
aiua-6490	57	5	,	,	PUNCT
aiua-6490	57	6	it	it	PRON
aiua-6490	57	7	should	should	AUX
aiua-6490	57	8	be	be	AUX
aiua-6490	57	9	considered	consider	VERB
aiua-6490	57	10	that	that	SCONJ
aiua-6490	57	11	venlafaxine	venlafaxine	NOUN
aiua-6490	57	12	monotherapy	monotherapy	NOUN
aiua-6490	57	13	can	can	AUX
aiua-6490	57	14	cause	cause	VERB
aiua-6490	57	15	lusss	lusss	NOUN
aiua-6490	57	16	and	and	CCONJ
aiua-6490	57	17	urinary	urinary	ADJ
aiua-6490	57	18	retention	retention	NOUN
aiua-6490	57	19	.	.	PUNCT
aiua-6490	58	1	references	reference	NOUN
aiua-6490	58	2	1	1	NUM
aiua-6490	58	3	.	.	PUNCT
aiua-6490	58	4	irwin	irwin	PROPN
aiua-6490	58	5	de	de	PROPN
aiua-6490	58	6	,	,	PUNCT
aiua-6490	58	7	et	et	PROPN
aiua-6490	58	8	al	al	PROPN
aiua-6490	58	9	.	.	PROPN
aiua-6490	58	10	,	,	PUNCT
aiua-6490	58	11	population	population	NOUN
aiua-6490	58	12	-	-	PUNCT
aiua-6490	58	13	based	base	VERB
aiua-6490	58	14	survey	survey	NOUN
aiua-6490	58	15	of	of	ADP
aiua-6490	58	16	urinary	urinary	ADJ
aiua-6490	58	17	incontinence	incontinence	NOUN
aiua-6490	58	18	,	,	PUNCT
aiua-6490	58	19	overactive	overactive	ADJ
aiua-6490	58	20	bladder	bladder	NOUN
aiua-6490	58	21	,	,	PUNCT
aiua-6490	58	22	and	and	CCONJ
aiua-6490	58	23	other	other	ADJ
aiua-6490	58	24	lower	low	ADJ
aiua-6490	58	25	urinary	urinary	ADJ
aiua-6490	58	26	tract	tract	NOUN
aiua-6490	58	27	symptoms	symptom	NOUN
aiua-6490	58	28	in	in	ADP
aiua-6490	58	29	five	five	NUM
aiua-6490	58	30	countries	country	NOUN
aiua-6490	58	31	:	:	PUNCT
aiua-6490	58	32	results	result	NOUN
aiua-6490	58	33	of	of	ADP
aiua-6490	58	34	the	the	DET
aiua-6490	58	35	epic	epic	ADJ
aiua-6490	58	36	study	study	NOUN
aiua-6490	58	37	.	.	PUNCT
aiua-6490	59	1	eur	eur	PROPN
aiua-6490	59	2	urol	urol	PROPN
aiua-6490	59	3	.	.	PUNCT
aiua-6490	60	1	2006	2006	NUM
aiua-6490	60	2	;	;	PUNCT
aiua-6490	60	3	50:1306	50:1306	NOUN
aiua-6490	60	4	-	-	SYM
aiua-6490	60	5	14	14	NUM
aiua-6490	60	6	.	.	PUNCT
aiua-6490	61	1	2	2	NUM
aiua-6490	61	2	.	.	X
aiua-6490	61	3	stahl	stahl	PROPN
aiua-6490	61	4	sm	sm	PROPN
aiua-6490	61	5	.	.	PROPN
aiua-6490	61	6	stahl	stahl	PROPN
aiua-6490	61	7	's	's	PART
aiua-6490	61	8	essential	essential	ADJ
aiua-6490	61	9	psychopharmacology	psychopharmacology	NOUN
aiua-6490	61	10	:	:	PUNCT
aiua-6490	61	11	neuroscientific	neuroscientific	ADJ
aiua-6490	61	12	basis	basis	NOUN
aiua-6490	61	13	and	and	CCONJ
aiua-6490	61	14	practical	practical	ADJ
aiua-6490	61	15	applications	application	NOUN
aiua-6490	61	16	.	.	PUNCT
aiua-6490	62	1	2013	2013	NUM
aiua-6490	62	2	:	:	PUNCT
aiua-6490	62	3	cambridge	cambridge	PROPN
aiua-6490	62	4	university	university	PROPN
aiua-6490	62	5	press	press	NOUN
aiua-6490	62	6	.	.	PUNCT
aiua-6490	63	1	3	3	X
aiua-6490	63	2	.	.	X
aiua-6490	63	3	rudolph	rudolph	PROPN
aiua-6490	63	4	rl	rl	PROPN
aiua-6490	63	5	,	,	PUNCT
aiua-6490	63	6	derivan	derivan	NOUN
aiua-6490	63	7	at	at	ADP
aiua-6490	63	8	.	.	PUNCT
aiua-6490	64	1	the	the	DET
aiua-6490	64	2	safety	safety	NOUN
aiua-6490	64	3	and	and	CCONJ
aiua-6490	64	4	tolerability	tolerability	NOUN
aiua-6490	64	5	of	of	ADP
aiua-6490	64	6	venlafaxine	venlafaxine	ADJ
aiua-6490	64	7	hydrochloride	hydrochloride	NOUN
aiua-6490	64	8	:	:	PUNCT
aiua-6490	64	9	analysis	analysis	NOUN
aiua-6490	64	10	of	of	ADP
aiua-6490	64	11	the	the	DET
aiua-6490	64	12	clinical	clinical	ADJ
aiua-6490	64	13	trials	trial	NOUN
aiua-6490	64	14	database	database	NOUN
aiua-6490	64	15	.	.	PUNCT
aiua-6490	65	1	j	j	PROPN
aiua-6490	65	2	clin	clin	PROPN
aiua-6490	65	3	psychopharmacol	psychopharmacol	PROPN
aiua-6490	65	4	.	.	PUNCT
aiua-6490	65	5	1996	1996	NUM
aiua-6490	65	6	;	;	PUNCT
aiua-6490	65	7	16(3	16(3	NUM
aiua-6490	65	8	suppl	suppl	ADJ
aiua-6490	65	9	2	2	NUM
aiua-6490	65	10	):	):	PUNCT
aiua-6490	65	11	p.	p.	NOUN
aiua-6490	65	12	54s-59s	54s-59s	NUM
aiua-6490	65	13	.	.	PUNCT
aiua-6490	66	1	4	4	X
aiua-6490	66	2	.	.	X
aiua-6490	66	3	cardozo	cardozo	PROPN
aiua-6490	66	4	l.	l.	PROPN
aiua-6490	66	5	voiding	void	VERB
aiua-6490	66	6	difficulties	difficulty	NOUN
aiua-6490	66	7	and	and	CCONJ
aiua-6490	66	8	retention	retention	NOUN
aiua-6490	66	9	.	.	PUNCT
aiua-6490	67	1	urogynecology	urogynecology	NOUN
aiua-6490	67	2	,	,	PUNCT
aiua-6490	67	3	1st	1st	ADJ
aiua-6490	67	4	ed	ed	NOUN
aiua-6490	67	5	.	.	PROPN
aiua-6490	67	6	,	,	PUNCT
aiua-6490	67	7	1997	1997	NUM
aiua-6490	67	8	,	,	PUNCT
aiua-6490	67	9	new	new	PROPN
aiua-6490	67	10	york	york	PROPN
aiua-6490	67	11	,	,	PUNCT
aiua-6490	67	12	ny	ny	PROPN
aiua-6490	67	13	:	:	PUNCT
aiua-6490	67	14	churchill	churchill	PROPN
aiua-6490	67	15	livingstone	livingstone	PROPN
aiua-6490	67	16	,	,	PUNCT
aiua-6490	67	17	305	305	NUM
aiua-6490	67	18	-	-	SYM
aiua-6490	67	19	320	320	NUM
aiua-6490	67	20	.	.	PUNCT
aiua-6490	68	1	5	5	NUM
aiua-6490	68	2	.	.	X
aiua-6490	68	3	thor	thor	PROPN
aiua-6490	68	4	kb	kb	PROPN
aiua-6490	68	5	,	,	PUNCT
aiua-6490	68	6	katofiasc	katofiasc	PROPN
aiua-6490	68	7	ma	ma	PROPN
aiua-6490	68	8	.	.	PROPN
aiua-6490	68	9	effects	effect	NOUN
aiua-6490	68	10	of	of	ADP
aiua-6490	68	11	duloxetine	duloxetine	NOUN
aiua-6490	68	12	,	,	PUNCT
aiua-6490	68	13	a	a	DET
aiua-6490	68	14	combined	combine	VERB
aiua-6490	68	15	serotonin	serotonin	NOUN
aiua-6490	68	16	and	and	CCONJ
aiua-6490	68	17	norepinephrine	norepinephrine	ADJ
aiua-6490	68	18	reuptake	reuptake	NOUN
aiua-6490	68	19	inhibitor	inhibitor	NOUN
aiua-6490	68	20	,	,	PUNCT
aiua-6490	68	21	on	on	ADP
aiua-6490	68	22	central	central	ADJ
aiua-6490	68	23	neural	neural	ADJ
aiua-6490	68	24	control	control	NOUN
aiua-6490	68	25	of	of	ADP
aiua-6490	68	26	lower	low	ADJ
aiua-6490	68	27	urinary	urinary	ADJ
aiua-6490	68	28	tract	tract	NOUN
aiua-6490	68	29	function	function	NOUN
aiua-6490	68	30	in	in	ADP
aiua-6490	68	31	the	the	DET
aiua-6490	68	32	chloralose	chloralose	NOUN
aiua-6490	68	33	-	-	PUNCT
aiua-6490	68	34	anesthetized	anesthetize	VERB
aiua-6490	68	35	female	female	ADJ
aiua-6490	68	36	cat	cat	NOUN
aiua-6490	68	37	.	.	PUNCT
aiua-6490	69	1	j	j	PROPN
aiua-6490	69	2	pharmacol	pharmacol	PROPN
aiua-6490	69	3	exp	exp	NOUN
aiua-6490	69	4	ther	ther	ADV
aiua-6490	69	5	.	.	PUNCT
aiua-6490	70	1	1995	1995	NUM
aiua-6490	70	2	;	;	PUNCT
aiua-6490	70	3	274:1014	274:1014	PROPN
aiua-6490	70	4	-	-	SYM
aiua-6490	70	5	24	24	NUM
aiua-6490	70	6	.	.	PUNCT
aiua-6490	71	1	6	6	NUM
aiua-6490	71	2	.	.	X
aiua-6490	71	3	akpınar	akpınar	PROPN
aiua-6490	71	4	a.	a.	NOUN
aiua-6490	71	5	milnasipran	milnasipran	NOUN
aiua-6490	71	6	tedavisine	tedavisine	VERB
aiua-6490	71	7	bağlı	bağlı	PROPN
aiua-6490	71	8	ani	ani	PROPN
aiua-6490	71	9	gelişen	gelişen	PROPN
aiua-6490	71	10	prostatizm	prostatizm	PROPN
aiua-6490	71	11	:	:	PUNCT
aiua-6490	71	12	bir	bir	PROPN
aiua-6490	71	13	olgu	olgu	PROPN
aiua-6490	71	14	sunumu	sunumu	PROPN
aiua-6490	71	15	.	.	PUNCT
aiua-6490	72	1	türk	türk	PROPN
aiua-6490	72	2	psikiyatri	psikiyatri	PROPN
aiua-6490	72	3	dergisi	dergisi	PROPN
aiua-6490	72	4	.	.	PROPN
aiua-6490	72	5	2009	2009	NUM
aiua-6490	72	6	;	;	PUNCT
aiua-6490	72	7	20:403	20:403	NUM
aiua-6490	72	8	.	.	PUNCT
aiua-6490	73	1	7	7	X
aiua-6490	73	2	.	.	X
aiua-6490	73	3	polimeni	polimeni	PROPN
aiua-6490	73	4	g	g	PROPN
aiua-6490	73	5	,	,	PUNCT
aiua-6490	73	6	salvo	salvo	NOUN
aiua-6490	73	7	f	f	PROPN
aiua-6490	73	8	,	,	PUNCT
aiua-6490	73	9	cutroneo	cutroneo	VERB
aiua-6490	73	10	p	p	X
aiua-6490	73	11	,	,	PUNCT
aiua-6490	73	12	et	et	PROPN
aiua-6490	73	13	al	al	PROPN
aiua-6490	73	14	.	.	PUNCT
aiua-6490	74	1	venlafaxine	venlafaxine	NOUN
aiua-6490	74	2	-	-	PUNCT
aiua-6490	74	3	induced	induce	VERB
aiua-6490	74	4	urinary	urinary	ADJ
aiua-6490	74	5	incontinence	incontinence	NOUN
aiua-6490	74	6	resolved	resolve	VERB
aiua-6490	74	7	after	after	ADP
aiua-6490	74	8	switching	switch	VERB
aiua-6490	74	9	to	to	PART
aiua-6490	74	10	sertraline	sertraline	PROPN
aiua-6490	74	11	.	.	PUNCT
aiua-6490	75	1	clin	clin	PROPN
aiua-6490	75	2	neuropharmacol	neuropharmacol	PROPN
aiua-6490	75	3	.	.	PUNCT
aiua-6490	76	1	2005	2005	NUM
aiua-6490	76	2	;	;	PUNCT
aiua-6490	76	3	28:247	28:247	NUM
aiua-6490	76	4	-	-	SYM
aiua-6490	76	5	8	8	NUM
aiua-6490	76	6	.	.	NOUN
aiua-6490	76	7	8	8	NUM
aiua-6490	76	8	.	.	PUNCT
aiua-6490	77	1	selvaraj	selvaraj	PROPN
aiua-6490	77	2	v	v	PROPN
aiua-6490	77	3	,	,	PUNCT
aiua-6490	77	4	gunasekar	gunasekar	PROPN
aiua-6490	77	5	p	p	X
aiua-6490	77	6	,	,	PUNCT
aiua-6490	77	7	kumar	kumar	PROPN
aiua-6490	77	8	s	s	PROPN
aiua-6490	77	9	,	,	PUNCT
aiua-6490	77	10	alsakaf	alsakaf	PROPN
aiua-6490	77	11	i.	i.	PROPN
aiua-6490	77	12	urinary	urinary	PROPN
aiua-6490	77	13	incontinence	incontinence	PROPN
aiua-6490	77	14	due	due	ADP
aiua-6490	77	15	to	to	ADP
aiua-6490	77	16	overactive	overactive	ADJ
aiua-6490	77	17	detrusor	detrusor	NOUN
aiua-6490	77	18	muscle	muscle	NOUN
aiua-6490	77	19	:	:	PUNCT
aiua-6490	77	20	a	a	DET
aiua-6490	77	21	rare	rare	ADJ
aiua-6490	77	22	side	side	NOUN
aiua-6490	77	23	effect	effect	NOUN
aiua-6490	77	24	of	of	ADP
aiua-6490	77	25	venlafaxine	venlafaxine	NOUN
aiua-6490	77	26	.	.	PUNCT
aiua-6490	78	1	case	case	NOUN
aiua-6490	78	2	rep	rep	PROPN
aiua-6490	78	3	urol	urol	PROPN
aiua-6490	78	4	.	.	PUNCT
aiua-6490	78	5	2015	2015	NUM
aiua-6490	78	6	;	;	PUNCT
aiua-6490	78	7	690931	690931	NUM
aiua-6490	78	8	.	.	PUNCT
aiua-6490	79	1	9	9	X
aiua-6490	79	2	.	.	X
aiua-6490	79	3	alexander	alexander	PROPN
aiua-6490	79	4	j	j	PROPN
aiua-6490	79	5	,	,	PUNCT
aiua-6490	79	6	mckenny	mckenny	PROPN
aiua-6490	79	7	b	b	PROPN
aiua-6490	79	8	,	,	PUNCT
aiua-6490	79	9	chaudhary	chaudhary	PROPN
aiua-6490	79	10	j.	j.	PROPN
aiua-6490	79	11	venlafaxine	venlafaxine	PROPN
aiua-6490	79	12	associated	associate	VERB
aiua-6490	79	13	urinary	urinary	ADJ
aiua-6490	79	14	symptoms	symptom	NOUN
aiua-6490	79	15	.	.	PUNCT
aiua-6490	80	1	aust	aust	PROPN
aiua-6490	80	2	n	n	PROPN
aiua-6490	80	3	z	z	PROPN
aiua-6490	80	4	j	j	PROPN
aiua-6490	80	5	psychiatry	psychiatry	NOUN
aiua-6490	80	6	.	.	PUNCT
aiua-6490	81	1	2010	2010	NUM
aiua-6490	81	2	;	;	PUNCT
aiua-6490	82	1	44:1145	44:1145	NUM
aiua-6490	82	2	.	.	PUNCT
aiua-6490	83	1	10	10	NUM
aiua-6490	83	2	.	.	PUNCT
aiua-6490	83	3	benazzi	benazzi	PROPN
aiua-6490	83	4	f.	f.	PROPN
aiua-6490	83	5	urinary	urinary	PROPN
aiua-6490	83	6	retention	retention	NOUN
aiua-6490	83	7	with	with	ADP
aiua-6490	83	8	venlafaxine	venlafaxine	NOUN
aiua-6490	83	9	-	-	PUNCT
aiua-6490	83	10	haloperidol	haloperidol	ADJ
aiua-6490	83	11	combination	combination	NOUN
aiua-6490	83	12	.	.	PUNCT
aiua-6490	84	1	pharmacopsychiatry	pharmacopsychiatry	NOUN
aiua-6490	84	2	.	.	PUNCT
aiua-6490	85	1	1997	1997	NUM
aiua-6490	85	2	;	;	PUNCT
aiua-6490	85	3	30:27	30:27	NUM
aiua-6490	85	4	.	.	PUNCT
aiua-6490	86	1	11	11	NUM
aiua-6490	86	2	.	.	X
aiua-6490	87	1	inghilleri	inghilleri	PROPN
aiua-6490	87	2	m	m	PROPN
aiua-6490	87	3	,	,	PUNCT
aiua-6490	87	4	conte	conte	PROPN
aiua-6490	87	5	a	a	PRON
aiua-6490	87	6	,	,	PUNCT
aiua-6490	87	7	frasca	frasca	PROPN
aiua-6490	87	8	v	v	NOUN
aiua-6490	87	9	,	,	PUNCT
aiua-6490	87	10	et	et	PROPN
aiua-6490	87	11	al	al	PROPN
aiua-6490	87	12	.	.	PROPN
aiua-6490	87	13	venlafaxine	venlafaxine	PROPN
aiua-6490	87	14	and	and	CCONJ
aiua-6490	87	15	bladder	bladder	NOUN
aiua-6490	87	16	function	function	NOUN
aiua-6490	87	17	.	.	PUNCT
aiua-6490	88	1	clin	clin	PROPN
aiua-6490	88	2	neuropharmacol	neuropharmacol	PROPN
aiua-6490	88	3	.	.	PUNCT
aiua-6490	89	1	2005	2005	NUM
aiua-6490	89	2	;	;	PUNCT
aiua-6490	89	3	28:270	28:270	NUM
aiua-6490	89	4	-	-	SYM
aiua-6490	89	5	3	3	NUM
aiua-6490	89	6	.	.	PUNCT
aiua-6490	89	7	correspondence	correspondence	NOUN
aiua-6490	89	8	şaban	şaban	NOUN
aiua-6490	90	1	oğuz	oğuz	NUM
aiua-6490	90	2	demirdöğen	demirdöğen	NOUN
aiua-6490	90	3	,	,	PUNCT
aiua-6490	90	4	md	md	PROPN
aiua-6490	90	5	oguzdemirdogen@hotmail.com	oguzdemirdogen@hotmail.com	PROPN
aiua-6490	91	1	şenol	şenol	PROPN
aiua-6490	91	2	adanur	adanur	PROPN
aiua-6490	91	3	,	,	PUNCT
aiua-6490	91	4	md	md	PROPN
aiua-6490	91	5	s.adanur61@hotmail.com	s.adanur61@hotmail.com	PROPN
aiua-6490	91	6	atatürk	atatürk	PROPN
aiua-6490	91	7	university	university	PROPN
aiua-6490	91	8	urology	urology	PROPN
aiua-6490	91	9	department	department	PROPN
aiua-6490	91	10	,	,	PUNCT
aiua-6490	91	11	turkey	turkey	NOUN
aiua-6490	91	12	esen	esen	PROPN
aiua-6490	91	13	yıldırım	yıldırım	PROPN
aiua-6490	91	14	demirdöğen	demirdöğen	NOUN
aiua-6490	91	15	,	,	PUNCT
aiua-6490	91	16	md	md	PROPN
aiua-6490	91	17	esenyildirim08@hotmail.com	esenyildirim08@hotmail.com	PROPN
aiua-6490	91	18	atatürk	atatürk	PROPN
aiua-6490	91	19	university	university	PROPN
aiua-6490	91	20	department	department	PROPN
aiua-6490	91	21	of	of	ADP
aiua-6490	91	22	child	child	NOUN
aiua-6490	91	23	and	and	CCONJ
aiua-6490	91	24	adolescent	adolescent	ADJ
aiua-6490	91	25	psychiatry	psychiatry	NOUN
aiua-6490	91	26	,	,	PUNCT
aiua-6490	91	27	turkey	turkey	PROPN
aiua-6490	91	28	demridogen_stesura	demridogen_stesura	PROPN
aiua-6490	91	29	seveso	seveso	PROPN
aiua-6490	91	30	26/06/17	26/06/17	PROPN
aiua-6490	91	31	09:01	09:01	NUM
aiua-6490	91	32	pagina	pagina	PROPN
aiua-6490	91	33	161	161	NUM